Recently, ARMH1 has been identified as a potential biomarker gene for the immunological score-based risk stratification signature in oral squamous cell carcinoma (58), but ARMH1 is still reported to be an unknown function gene and has not been studied in detail in cancer, especially leukemias. Here, ARMH1 is linked to leukemia.